• レポートコード:MRC2-11QY04793 • 出版社/出版日:QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、95ページ • 納品方法:Eメール(納期:2~3日) • 産業分類:ヘルスケア |
Single User | ¥585,000 (USD3,900) | ▷ お問い合わせ |
Multi User | ¥877,500 (USD5,850) | ▷ お問い合わせ |
Enterprise License | ¥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料はターゲットデリバリドラッグのグローバル市場について調査・分析したレポートです。種類別(眼のドラッグデリバリー、肺のドラッグデリバリー、薬剤溶出ステント、その他)市場規模、用途別(病院、診療所、その他)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ターゲットデリバリドラッグの競争状況、市場シェア ・世界のターゲットデリバリドラッグ市場:種類別市場規模 2015年-2020年(眼のドラッグデリバリー、肺のドラッグデリバリー、薬剤溶出ステント、その他) ・世界のターゲットデリバリドラッグ市場:種類別市場規模予測 2021年-2026年(眼のドラッグデリバリー、肺のドラッグデリバリー、薬剤溶出ステント、その他) ・世界のターゲットデリバリドラッグ市場:用途別市場規模 2015年-2020年(病院、診療所、その他) ・世界のターゲットデリバリドラッグ市場:用途別市場規模予測 2021年-2026年(病院、診療所、その他) ・北米のターゲットデリバリドラッグ市場分析:米国、カナダ ・ヨーロッパのターゲットデリバリドラッグ市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのターゲットデリバリドラッグ市場分析:日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のターゲットデリバリドラッグ市場分析:メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのターゲットデリバリドラッグ市場分析:トルコ、サウジアラビア、UAE等 ・企業情報(企業概要、製品概要、販売量、企業動向) - 掲載企業(変更可能性あり):Adverum、Arrowhead Pharmaceuticals、Bayer、Windtree Therapeutics、Immunocore、Mankind Pharma、Roche、Ra Pharma、Keystone Nano、Lipocine、MultiVir ・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Targeted delivery of drugs is defined as a method of injecting drugs into the body so that they only target specific parts of the body. Targeted delivery of drugs is designed to target, extend and protect interactions with diseased tissues.
Market Analysis and Insights: Global Targeted Delivery Drugs Market
The global Targeted Delivery Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Targeted Delivery Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Targeted Delivery Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Targeted Delivery Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Targeted Delivery Drugs market.
Global Targeted Delivery Drugs Scope and Market Size
Targeted Delivery Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Targeted Delivery Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
Ocular Drug Delivery
Pulmonary Drug Delivery
Drug Eluting Stents
Other
Market segment by Application, split into
Hospital
Clinic
Other
Based on regional and country-level analysis, the Targeted Delivery Drugs market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Targeted Delivery Drugs market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Adverum
Arrowhead Pharmaceuticals
Bayer
Windtree Therapeutics
Immunocore
Mankind Pharma
Roche
Ra Pharma
Keystone Nano
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted Delivery Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Ocular Drug Delivery
1.2.3 Pulmonary Drug Delivery
1.2.4 Drug Eluting Stents
1.2.5 Other
1.3 Market by Application
1.3.1 Global Targeted Delivery Drugs Market Share by Application: 2020 VS 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Targeted Delivery Drugs Market Perspective (2015-2026)
2.2 Global Targeted Delivery Drugs Growth Trends by Regions
2.2.1 Targeted Delivery Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Targeted Delivery Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Targeted Delivery Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Targeted Delivery Drugs Players by Market Size
3.1.1 Global Top Targeted Delivery Drugs Players by Revenue (2015-2020)
3.1.2 Global Targeted Delivery Drugs Revenue Market Share by Players (2015-2020)
3.2 Global Targeted Delivery Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Targeted Delivery Drugs Revenue
3.4 Global Targeted Delivery Drugs Market Concentration Ratio
3.4.1 Global Targeted Delivery Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Delivery Drugs Revenue in 2019
3.5 Key Players Targeted Delivery Drugs Area Served
3.6 Key Players Targeted Delivery Drugs Product Solution and Service
3.7 Date of Enter into Targeted Delivery Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted Delivery Drugs Breakdown Data by Type (2015-2026)
4.1 Global Targeted Delivery Drugs Historic Market Size by Type (2015-2020)
4.2 Global Targeted Delivery Drugs Forecasted Market Size by Type (2021-2026)
5 Targeted Delivery Drugs Breakdown Data by Application (2015-2026)
5.1 Global Targeted Delivery Drugs Historic Market Size by Application (2015-2020)
5.2 Global Targeted Delivery Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Targeted Delivery Drugs Market Size (2015-2026)
6.2 North America Targeted Delivery Drugs Market Size by Type (2015-2020)
6.3 North America Targeted Delivery Drugs Market Size by Application (2015-2020)
6.4 North America Targeted Delivery Drugs Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Targeted Delivery Drugs Market Size (2015-2026)
7.2 Europe Targeted Delivery Drugs Market Size by Type (2015-2020)
7.3 Europe Targeted Delivery Drugs Market Size by Application (2015-2020)
7.4 Europe Targeted Delivery Drugs Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Targeted Delivery Drugs Market Size (2015-2026)
8.2 China Targeted Delivery Drugs Market Size by Type (2015-2020)
8.3 China Targeted Delivery Drugs Market Size by Application (2015-2020)
8.4 China Targeted Delivery Drugs Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Targeted Delivery Drugs Market Size (2015-2026)
9.2 Japan Targeted Delivery Drugs Market Size by Type (2015-2020)
9.3 Japan Targeted Delivery Drugs Market Size by Application (2015-2020)
9.4 Japan Targeted Delivery Drugs Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Targeted Delivery Drugs Market Size (2015-2026)
10.2 Southeast Asia Targeted Delivery Drugs Market Size by Type (2015-2020)
10.3 Southeast Asia Targeted Delivery Drugs Market Size by Application (2015-2020)
10.4 Southeast Asia Targeted Delivery Drugs Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11Key Players Profiles
11.1 Adverum
11.1.1 Adverum Company Details
11.1.2 Adverum Business Overview
11.1.3 Adverum Targeted Delivery Drugs Introduction
11.1.4 Adverum Revenue in Targeted Delivery Drugs Business (2015-2020))
11.1.5 Adverum Recent Development
11.2 Arrowhead Pharmaceuticals
11.2.1 Arrowhead Pharmaceuticals Company Details
11.2.2 Arrowhead Pharmaceuticals Business Overview
11.2.3 Arrowhead Pharmaceuticals Targeted Delivery Drugs Introduction
11.2.4 Arrowhead Pharmaceuticals Revenue in Targeted Delivery Drugs Business (2015-2020)
11.2.5 Arrowhead Pharmaceuticals Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Targeted Delivery Drugs Introduction
11.3.4 Bayer Revenue in Targeted Delivery Drugs Business (2015-2020)
11.3.5 Bayer Recent Development
11.4 Windtree Therapeutics
11.4.1 Windtree Therapeutics Company Details
11.4.2 Windtree Therapeutics Business Overview
11.4.3 Windtree Therapeutics Targeted Delivery Drugs Introduction
11.4.4 Windtree Therapeutics Revenue in Targeted Delivery Drugs Business (2015-2020)
11.4.5 Windtree Therapeutics Recent Development
11.5 Immunocore
11.5.1 Immunocore Company Details
11.5.2 Immunocore Business Overview
11.5.3 Immunocore Targeted Delivery Drugs Introduction
11.5.4 Immunocore Revenue in Targeted Delivery Drugs Business (2015-2020)
11.5.5 Immunocore Recent Development
11.6 Mankind Pharma
11.6.1 Mankind Pharma Company Details
11.6.2 Mankind Pharma Business Overview
11.6.3 Mankind Pharma Targeted Delivery Drugs Introduction
11.6.4 Mankind Pharma Revenue in Targeted Delivery Drugs Business (2015-2020)
11.6.5 Mankind Pharma Recent Development
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Targeted Delivery Drugs Introduction
11.7.4 Roche Revenue in Targeted Delivery Drugs Business (2015-2020)
11.7.5 Roche Recent Development
11.8 Ra Pharma
11.8.1 Ra Pharma Company Details
11.8.2 Ra Pharma Business Overview
11.8.3 Ra Pharma Targeted Delivery Drugs Introduction
11.8.4 Ra Pharma Revenue in Targeted Delivery Drugs Business (2015-2020)
11.8.5 Ra Pharma Recent Development
11.9 Keystone Nano
11.9.1 Keystone Nano Company Details
11.9.2 Keystone Nano Business Overview
11.9.3 Keystone Nano Targeted Delivery Drugs Introduction
11.9.4 Keystone Nano Revenue in Targeted Delivery Drugs Business (2015-2020)
11.9.5 Keystone Nano Recent Development
11.10 Lipocine
11.10.1 Lipocine Company Details
11.10.2 Lipocine Business Overview
11.10.3 Lipocine Targeted Delivery Drugs Introduction
11.10.4 Lipocine Revenue in Targeted Delivery Drugs Business (2015-2020)
11.10.5 Lipocine Recent Development
11.11 MultiVir
10.11.1 MultiVir Company Details
10.11.2 MultiVir Business Overview
10.11.3 MultiVir Targeted Delivery Drugs Introduction
10.11.4 MultiVir Revenue in Targeted Delivery Drugs Business (2015-2020)
10.11.5 MultiVir Recent Development
12Analyst’s Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Targeted Delivery Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Ocular Drug Delivery
Table 4. Key Players of Pulmonary Drug Delivery
Table 5. Key Players of Drug Eluting Stents
Table 6. Key Players of Other
Table 7. Global Targeted Delivery Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Targeted Delivery Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Targeted Delivery Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Targeted Delivery Drugs Market Share by Regions (2015-2020)
Table 11. Global Targeted Delivery Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Targeted Delivery Drugs Market Share by Regions (2021-2026)
Table 13. Targeted Delivery Drugs Market Market Trends
Table 14. Targeted Delivery Drugs Market Drivers
Table 15. Targeted Delivery Drugs Market Challenges
Table 16. Targeted Delivery Drugs Market Restraints
Table 17. Global Targeted Delivery Drugs Revenue by Players (2015-2020) (US$ Million)
Table 18. Global Targeted Delivery Drugs Market Share by Players (2015-2020)
Table 19. Global Top Targeted Delivery Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Targeted Delivery Drugs as of 2019)
Table 20. Global Targeted Delivery Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Targeted Delivery Drugs Product Solution and Service
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Targeted Delivery Drugs Market Size by Type (2015-2020) (US$ Million)
Table 25. Global Targeted Delivery Drugs Market Size Share by Type (2015-2020)
Table 26. Global Targeted Delivery Drugs Revenue Market Share by Type (2021-2026)
Table 27. Global Targeted Delivery Drugs Market Size Share by Application (2015-2020)
Table 28. Global Targeted Delivery Drugs Market Size by Application (2015-2020) (US$ Million)
Table 29. Global Targeted Delivery Drugs Market Size Share by Application (2021-2026)
Table 30. North America Targeted Delivery Drugs Market Size by Type (2015-2020) (US$ Million)
Table 31. North America Targeted Delivery Drugs Market Share by Type (2015-2020)
Table 32. North America Targeted Delivery Drugs Market Size by Application (2015-2020) (US$ Million)
Table 33. North America Targeted Delivery Drugs Market Share by Application (2015-2020)
Table 34. North America Targeted Delivery Drugs Market Size by Country (US$ Million) (2015-2020)
Table 35. North America Targeted Delivery Drugs Market Share by Country (2015-2020)
Table 36. Europe Targeted Delivery Drugs Market Size by Type (2015-2020) (US$ Million)
Table 37. Europe Targeted Delivery Drugs Market Share by Type (2015-2020)
Table 38. Europe Targeted Delivery Drugs Market Size by Application (2015-2020) (US$ Million)
Table 39. Europe Targeted Delivery Drugs Market Share by Application (2015-2020)
Table 40. Europe Targeted Delivery Drugs Market Size by Country (US$ Million) (2015-2020)
Table 41. Europe Targeted Delivery Drugs Market Share by Country (2015-2020)
Table 42. China Targeted Delivery Drugs Market Size by Type (2015-2020) (US$ Million)
Table 43. China Targeted Delivery Drugs Market Share by Type (2015-2020)
Table 44. China Targeted Delivery Drugs Market Size by Application (2015-2020) (US$ Million)
Table 45. China Targeted Delivery Drugs Market Share by Application (2015-2020)
Table 46. China Targeted Delivery Drugs Market Size by Region (US$ Million) (2015-2020)
Table 47. China Targeted Delivery Drugs Market Share by Region (2015-2020)
Table 48. Japan Targeted Delivery Drugs Market Size by Type (2015-2020) (US$ Million)
Table 49. Japan Targeted Delivery Drugs Market Share by Type (2015-2020)
Table 50. Japan Targeted Delivery Drugs Market Size by Application (2015-2020) (US$ Million)
Table 51. Japan Targeted Delivery Drugs Market Share by Application (2015-2020)
Table 52. Japan Targeted Delivery Drugs Market Size by Country (US$ Million) (2015-2020)
Table 53. Japan Targeted Delivery Drugs Market Share by Country (2015-2020)
Table 54. Southeast Asia Targeted Delivery Drugs Market Size by Type (2015-2020) (US$ Million)
Table 55. Southeast Asia Targeted Delivery Drugs Market Share by Type (2015-2020)
Table 56. Southeast Asia Targeted Delivery Drugs Market Size by Application (2015-2020) (US$ Million)
Table 57. Southeast Asia Targeted Delivery Drugs Market Share by Application (2015-2020)
Table 58. Southeast Asia Targeted Delivery Drugs Market Size by Country (US$ Million) (2015-2020)
Table 59. Southeast Asia Targeted Delivery Drugs Market Share by Country (2015-2020)
Table 60. Adverum Company Details
Table 61. Adverum Business Overview
Table 62. Adverum Product
Table 63. Adverum Revenue in Targeted Delivery Drugs Business (2015-2020) (US$ Million)
Table 64. Adverum Recent Development
Table 65. Arrowhead Pharmaceuticals Company Details
Table 66. Arrowhead Pharmaceuticals Business Overview
Table 67. Arrowhead Pharmaceuticals Product
Table 68. Arrowhead Pharmaceuticals Revenue in Targeted Delivery Drugs Business (2015-2020) (US$ Million)
Table 69. Arrowhead Pharmaceuticals Recent Development
Table 70. Bayer Company Details
Table 71. Bayer Business Overview
Table 72. Bayer Product
Table 73. Bayer Revenue in Targeted Delivery Drugs Business (2015-2020) (US$ Million)
Table 74. Bayer Recent Development
Table 75. Windtree Therapeutics Company Details
Table 76. Windtree Therapeutics Business Overview
Table 77. Windtree Therapeutics Product
Table 78. Windtree Therapeutics Revenue in Targeted Delivery Drugs Business (2015-2020) (US$ Million)
Table 79. Windtree Therapeutics Recent Development
Table 80. Immunocore Company Details
Table 81. Immunocore Business Overview
Table 82. Immunocore Product
Table 83. Immunocore Revenue in Targeted Delivery Drugs Business (2015-2020) (US$ Million)
Table 84. Immunocore Recent Development
Table 85. Mankind Pharma Company Details
Table 86. Mankind Pharma Business Overview
Table 87. Mankind Pharma Product
Table 88. Mankind Pharma Revenue in Targeted Delivery Drugs Business (2015-2020) (US$ Million)
Table 89. Mankind Pharma Recent Development
Table 90. Roche Company Details
Table 91. Roche Business Overview
Table 92. Roche Product
Table 93. Roche Revenue in Targeted Delivery Drugs Business (2015-2020) (US$ Million)
Table 94. Roche Recent Development
Table 95. Ra Pharma Business Overview
Table 96. Ra Pharma Product
Table 97. Ra Pharma Company Details
Table 98. Ra Pharma Revenue in Targeted Delivery Drugs Business (2015-2020) (US$ Million)
Table 99. Ra Pharma Recent Development
Table 100. Keystone Nano Company Details
Table 101. Keystone Nano Business Overview
Table 102. Keystone Nano Product
Table 103. Keystone Nano Revenue in Targeted Delivery Drugs Business (2015-2020) (US$ Million)
Table 104. Keystone Nano Recent Development
Table 105. Lipocine Company Details
Table 106. Lipocine Business Overview
Table 107. Lipocine Product
Table 108. Lipocine Revenue in Targeted Delivery Drugs Business (2015-2020) (US$ Million)
Table 109. Lipocine Recent Development
Table 110. MultiVir Company Details
Table 111. MultiVir Business Overview
Table 112. MultiVir Product
Table 113. MultiVir Revenue in Targeted Delivery Drugs Business (2015-2020) (US$ Million)
Table 114. MultiVir Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Targeted Delivery Drugs Market Share by Type: 2020 VS 2026
Figure 2. Ocular Drug Delivery Features
Figure 3. Pulmonary Drug Delivery Features
Figure 4. Drug Eluting Stents Features
Figure 5. Other Features
Figure 6. Global Targeted Delivery Drugs Market Share by Application: 2020 VS 2026
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Targeted Delivery Drugs Report Years Considered
Figure 11. Global Targeted Delivery Drugs Market Size (US$ Million), YoY Growth 2015-2026
Figure 12. Global Targeted Delivery Drugs Market Share by Regions: 2020 VS 2026
Figure 13. Global Targeted Delivery Drugs Market Share by Regions (2021-2026)
Figure 14. Global Targeted Delivery Drugs Market Share by Players in 2019
Figure 15. Global Top Targeted Delivery Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Targeted Delivery Drugs as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Targeted Delivery Drugs Revenue in 2019
Figure 17. North America Targeted Delivery Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. United States Targeted Delivery Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Canada Targeted Delivery Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Europe Targeted Delivery Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Germany Targeted Delivery Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. France Targeted Delivery Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. U.K. Targeted Delivery Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Italy Targeted Delivery Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Russia Targeted Delivery Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Nordic Targeted Delivery Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Rest of Europe Targeted Delivery Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Asia-Pacific Targeted Delivery Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. China Targeted Delivery Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Japan Targeted Delivery Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. South Korea Targeted Delivery Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Southeast Asia Targeted Delivery Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. India Targeted Delivery Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Australia Targeted Delivery Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Rest of Asia-Pacific Targeted Delivery Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Latin America Targeted Delivery Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Mexico Targeted Delivery Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Brazil Targeted Delivery Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Middle East & Africa Targeted Delivery Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Turkey Targeted Delivery Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Saudi Arabia Targeted Delivery Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. UAE Targeted Delivery Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Rest of Middle East & Africa Targeted Delivery Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Adverum Revenue Growth Rate in Targeted Delivery Drugs Business (2015-2020)
Figure 45. Arrowhead Pharmaceuticals Revenue Growth Rate in Targeted Delivery Drugs Business (2015-2020)
Figure 46. Bayer Revenue Growth Rate in Targeted Delivery Drugs Business (2015-2020)
Figure 47. Windtree Therapeutics Revenue Growth Rate in Targeted Delivery Drugs Business (2015-2020)
Figure 48. Immunocore Revenue Growth Rate in Targeted Delivery Drugs Business (2015-2020)
Figure 49. Mankind Pharma Revenue Growth Rate in Targeted Delivery Drugs Business (2015-2020)
Figure 50. Roche Revenue Growth Rate in Targeted Delivery Drugs Business (2015-2020)
Figure 51. Ra Pharma Revenue Growth Rate in Targeted Delivery Drugs Business (2015-2020)
Figure 52. Keystone Nano Revenue Growth Rate in Targeted Delivery Drugs Business (2015-2020)
Figure 53. Lipocine Revenue Growth Rate in Targeted Delivery Drugs Business (2015-2020)
Figure 54. MultiVir Revenue Growth Rate in Targeted Delivery Drugs Business (2015-2020)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed